Y-MABS THERAPEUTICS INC. - COMMON STOCK
11.59
14-November-24 16:45:00
15 minutes delayed
Stocks
-1.59
-12.06%
Today's range
11.50 - 12.97
ISIN
N/A
Source
NASDAQ
-
Y-mAbs Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate Developments
30 Mar 2023 16:01:00 By Nasdaq GlobeNewswire
-
Y-mAbs to Announce 2022 Financial and Operating Results on March 30, 2023
21 Mar 2023 16:01:00 By Nasdaq GlobeNewswire
-
02 Feb 2023 09:00:00 By Nasdaq GlobeNewswire
-
04 Jan 2023 16:01:00 By Nasdaq GlobeNewswire
-
Y-mAbs Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 09:00:00 By Nasdaq GlobeNewswire
-
Y-mAbs Announces Partnership Regarding Early Access Program for DANYELZA (naxitamab-gqgk) in Europe
21 Dec 2022 09:00:00 By Nasdaq GlobeNewswire
-
16 Dec 2022 16:01:00 By Nasdaq GlobeNewswire
-
Y-mAbs Announces Pipeline Update
14 Dec 2022 09:00:01 By Nasdaq GlobeNewswire
-
Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of High-Risk Neuroblastoma Approved in China
08 Dec 2022 09:00:00 By Nasdaq GlobeNewswire
-
Y-mAbs to Host Annual Research and Development Day in New York
06 Dec 2022 09:00:01 By Nasdaq GlobeNewswire
-
Y-mAbs Announces Complete Response Letter for Omburtamab Biologics License Application
01 Dec 2022 17:34:16 By Nasdaq GlobeNewswire
-
Y-mAbs Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
07 Nov 2022 16:01:00 By Nasdaq GlobeNewswire
-
Y-mAbs to Announce Third Quarter 2022 Financial and Operating Results on November 7, 2022
02 Nov 2022 16:01:00 By Nasdaq GlobeNewswire
-
Y-mAbs Announces Outcome of FDA Advisory Committee Meeting on Omburtamab
28 Oct 2022 15:33:33 By Nasdaq GlobeNewswire
-
Y-mAbs Announces Pivotal Data for Omburtamab
03 Oct 2022 09:00:01 By Nasdaq GlobeNewswire
-
Y-mAbs Announces Regulatory Filing for DANYELZA® (naxitamab-gqgk) in Brazil
26 Sep 2022 09:00:00 By Nasdaq GlobeNewswire
-
Y-mAbs Announces Scheduling of FDA Advisory Committee Meeting for Omburtamab
01 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
30 Aug 2022 09:00:01 By Nasdaq GlobeNewswire
-
Y-mAbs Announces Second Quarter Financial Results and Recent Corporate Developments
08 Aug 2022 16:05:02 By Nasdaq GlobeNewswire
-
Y-mAbs to Announce Second Quarter 2022 Financial and Operating Results on August 8, 2022
02 Aug 2022 09:00:00 By Nasdaq GlobeNewswire